TMT1B and metabolic dysfunction-associated steatohepatitis: METTL7B is involved in various diseases such as sepsis (34), lipid metabolism in non-alcoholic steatohepatitis (35, 36), and several tumors, including breast cancer (37), thyroid cancer (38), lung adenocarcinoma (39), and non–small cell lung cancer (40).